CN103355578A - Soybean peptide nutritional and health tablet - Google Patents
Soybean peptide nutritional and health tablet Download PDFInfo
- Publication number
- CN103355578A CN103355578A CN2012101089719A CN201210108971A CN103355578A CN 103355578 A CN103355578 A CN 103355578A CN 2012101089719 A CN2012101089719 A CN 2012101089719A CN 201210108971 A CN201210108971 A CN 201210108971A CN 103355578 A CN103355578 A CN 103355578A
- Authority
- CN
- China
- Prior art keywords
- tablet
- health
- soybean peptide
- soybean
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 55
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 28
- 244000068988 Glycine max Species 0.000 title claims abstract description 23
- 230000036541 health Effects 0.000 title abstract description 29
- 235000016709 nutrition Nutrition 0.000 title abstract description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 46
- 229920001184 polypeptide Polymers 0.000 claims description 44
- 239000002994 raw material Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 7
- 239000005913 Maltodextrin Substances 0.000 abstract description 6
- 229920002774 Maltodextrin Polymers 0.000 abstract description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract description 6
- 229940035034 maltodextrin Drugs 0.000 abstract description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract description 6
- 235000010447 xylitol Nutrition 0.000 abstract description 6
- 239000000811 xylitol Substances 0.000 abstract description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract description 6
- 229960002675 xylitol Drugs 0.000 abstract description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 4
- 229920001503 Glucan Polymers 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 235000019658 bitter taste Nutrition 0.000 abstract description 2
- 235000012000 cholesterol Nutrition 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 210000000936 intestine Anatomy 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 108010046377 Whey Proteins Proteins 0.000 abstract 1
- 102000007544 Whey Proteins Human genes 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 235000013365 dairy product Nutrition 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000008821 health effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000021119 whey protein Nutrition 0.000 abstract 1
- 235000008935 nutritious Nutrition 0.000 description 26
- 241000699666 Mus <mouse, genus> Species 0.000 description 24
- 239000003826 tablet Substances 0.000 description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 230000009182 swimming Effects 0.000 description 14
- 235000020197 coconut milk Nutrition 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 235000014655 lactic acid Nutrition 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 150000002576 ketones Chemical class 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 5
- 229920002527 Glycogen Polymers 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000004376 Sucralose Substances 0.000 description 5
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 5
- 229940096919 glycogen Drugs 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 5
- 235000019408 sucralose Nutrition 0.000 description 5
- 235000019871 vegetable fat Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 241001125929 Trisopterus luscus Species 0.000 description 3
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 239000011155 wood-plastic composite Substances 0.000 description 2
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention provides a soybean peptide nutritional and health tablet. The tablet is prepared from soybean peptide powder, xylitol, whey protein concentrate, glucan, maltodextrin, non-dairy creamer and the like according to proportions. The soybean peptide nutritional and health-care tablet fully utilizes the health effect of soybean peptides and contains additional nutritional ingredients, so that the tablet further has functional effect. After being taken for a long term, the tablet can reduce cholesterol, blood pressure and blood sugar, improve the functions of intestines and stomachs improve the organism immunity and delay the body degradation and aging. The tablet is convenient to carry, can be used for supplementing nutrients during trips, improves undesirable characteristics of soybean peptides such as heavy bitter taste and poor taste, and has good palatability.
Description
Technical field
The present invention relates to a kind of tablet with physiological function, relate in particular to a kind of soya-bean polypeptides healthy tablet.
Background technology
Soya-bean polypeptides be soybean protein through the protease effect, the protein hydrolysate that obtains through specially treated again.The essential amino acid of soya-bean polypeptides forms with soybean protein just the same, rich content and balance, and polypeptide compound is easily digested, has the blood fat of reduction effect, it has prevention of obesity, reduces cholesterolemia, reduces blood pressure, increases the effects such as bone density, prevention of osteoporosis, has the characteristics of low antigen.There are the problems such as mouthfeel is poor, taste is not enough in existing soya-bean polypeptides product take albumen powder and chewable tablets as main.
Summary of the invention
Technical problem to be solved by this invention is, a kind of soya-bean polypeptides healthy tablet is provided, and taking full advantage of the health-care effect of soya-bean polypeptides, and improves its palatability.
The present invention is achieved in that a kind of soya-bean polypeptides healthy tablet, and it is to be made by the raw material of following proportioning,
This soya-bean polypeptides healthy tablet takes full advantage of the health-care effect of soya-bean polypeptides, and has replenished nutritional labeling, makes it have more function affect.Long-term taking can reduce cholesterol, blood pressure and blood sugar, improves functions of intestines and stomach, improves immunity of organisms, and delaying human body is degenerated, worn out.Easy to carry, can be used for supplementing the nutrients in the travelling.Soya-bean polypeptides heavy bitter taste, the poor undesirable feature of mouthfeel have been improved, good palatability.
The specific embodiment
The below further specifies the present invention.
During preparation, soy peptide powder, xylitol, WPC, glucan, maltodextrin and vegetable fat powder are put into fully mixing of trough type mixing machine, get first mixture.In addition, Sucralose, coconut milk essence, dolomol, superfine silica gel powder, milk flavour and toot muttered adds part (such as 1/5th) above-mentioned first mixture behind the ketone mixing, the classification mixing, mixture again.At last will be for the first time, mixture merges mixing again.Use again the tablet press machine compressing tablet, make the soya-bean polypeptides healthy tablet.Every weight is 1g.
This product is nutraceutical, can early take each two before the meal or before and after the motion.Also can be edible according to physical consumption or tired degree dosage.
The pure fragrant coconut milk essence that spices Co., Ltd produces is contained in XW264251 coconut milk essence or sea, Yangdong County that described coconut milk essence can adopt Shanghai fragrant prestige essence and flavoring agent Co., Ltd to produce.Also can adopt the coconut milk essence that can be used for food of other manufacturer production.
The product that described milk flavour can adopt Shenzhen taste bud essence and flavoring agent Co., Ltd to produce.
The described toot product that ketone can adopt Fen Meiyi (Firmenich) company to produce of muttering.Its chemical name is: 4-hydroxyl-2,5-dimethyl-3 (2H)-furanone.
Be checking the present invention's the concrete health-care effect of health products, verified this tablet in the physiological action aspect the alleviation organism fatigue by Bioexperiment, concrete outcome is as follows:
One, the nutritious health polypeptide sheet is on the impact of Mouse Weight
The impact that table 1-1 nutritious health polypeptide sheet is tested Mouse Weight (X ± SD)
By table 1-1 as seen, per os gives the different nutritious health polypeptide sheet of mouse before and after 4 weeks, compares with the blank group, and each dosage group body weight is all without significant difference (P＞0.05).
Two, the nutritious health polypeptide sheet is on the impact of mouse swimming test
Table 2-1 nutritious health polypeptide sheet is on the impact of mouse swimming test (X ± SD)
*: relatively there were significant differences (P＜0.05) with the blank group
*: with the blank group highly significant difference (P＜0.01) is arranged relatively
By table 2-1 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compare with the blank group, basic, normal, high dosage group swimming time prolongs respectively 142% (P＜0.01), 110% (P＜0.05), 125% (P＜0.05).
Three, the nutritious health polypeptide sheet is on the impact of mouse pole-jump test
Table 3-1 nutritious health polypeptide sheet is on the impact of mouse pole-jump test (X ± SD)
*: relatively there were significant differences (P＜0.05) with the blank group
*: with the blank group highly significant difference (P＜0.01) is arranged relatively
By table 3-1 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compare with the blank group, the basic, normal, high dosage group pole-climbing time prolongs respectively 111% (P＜0.01), 167% (P＜0.05) and 136% (P＜0.05).
Four, the nutritious health polypeptide sheet is on the impact of mice serum urea nitrogen
Table 4-1 nutritious health polypeptide sheet is on the impact of mice serum urea nitrogen (X ± SD)
*: relatively there were significant differences (P＜0.05) with the blank group
By table 4-1 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compares with the blank group, and the high dose group urea nitrogen content reduces by 13% (P＜0.05).
Five, the nutritious health polypeptide sheet is on the impact of Mouse Blood lactic acid
Table 5-1 nutritious health polypeptide sheet is on the impact of Mouse Blood lactic acid (before the swimming) (X ± SD)
By table 5-1 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compares with the blank group, and blood lactate concentration is all without significant difference (P＞0.05) before each dosage group swimming.
Table 5-2 nutritious health polypeptide sheet is on the impact of Mouse Blood lactic acid (0min after the swimming) (X ± SD)
By table 5-2 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compares with the blank group, and the 0min blood lactate concentration is all without significant difference (P＞0.05) after each dosage group swimming.
Table 5-3 nutritious health polypeptide sheet is on the impact of Mouse Blood lactic acid (20min after the swimming) (X ± SD)
By table 5-3 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compares with the blank group, and the 20min blood lactate concentration is all without significant difference (P＞0.05) after each dosage group swimming.
The impact of table 5-4 nutritious health polypeptide sheet Mouse Blood lactic acid rising ratio (X ± SD)
By table 5-4 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compares with the blank group, and 0min blood lactic acid rising ratio is all without significant difference (P＞0.05) after each dosage group swimming.
Table 5-5 nutritious health polypeptide sheet is on the impact of mouse blood lactate removal ratio (X ± SD)
*: relatively there were significant differences (P＜0.05) with the blank group
By table 5-5 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compares with the blank group, and the 20min blood lactate removal is than improving 21% (P＜0.05) after the high dose group swimming.
Six, the nutritious health polypeptide sheet is on the impact of Mouse Liver glycogen
Table 6-1 nutritious health polypeptide sheet is on the impact of Mouse Liver glycogen (X ± SD)
By table 6-1 as seen, per os gives the nutritious health polypeptide sheet of mouse various dose after 4 weeks, compares with the blank group, and each dosage group hepatic glycogen content is all without significant difference (P＞0.05).
Experiment shows, per os gives the various dose electuary after 4 weeks, with the blank group relatively, the low dose group swimming time prolongs 142%, pole-climbing time lengthening 111%, other each indexs there are no significant difference; Middle dosage group swimming time prolongs 110%, pole-climbing time lengthening 167%, blood lactic acid, serum urea nitrogen content, hepatic glycogen content there are no significant difference; High dose group swimming time prolongation 125%, pole-climbing time lengthening 136%, serum urea nitrogen content 13%, blood lactate removal ratio improves 21%, the hepatic glycogen content there was no significant difference.Each dosage group body weight there are no significant difference.
Can find out from top data, the present invention can significantly improve body vigor, fatigue-relieving.
Embodiment 1
A kind of soya-bean polypeptides healthy tablet, it is to be made by the raw material of following proportioning, soy peptide powder 6 weight portions, xylitol 22 weight portions, WPC 0.5 weight portion, Dextran 45 weight portion, maltodextrin 25 weight portions, vegetable fat powder 4 weight portions, dolomol 0.24 weight portion, Sucralose 0.01 weight portion, coconut milk essence 0.2 weight portion, superfine silica gel powder 0.9 weight portion, ketone 0.15 weight portion, milk flavour 0.5 weight portion of muttering of pouting.
During preparation, soy peptide powder, xylitol, WPC, glucan, maltodextrin and vegetable fat powder are put into fully mixing of trough type mixing machine, get first mixture.In addition, Sucralose, coconut milk essence, dolomol, superfine silica gel powder, milk flavour and toot muttered adds part (such as 1/5th) above-mentioned first mixture behind the ketone mixing, the classification mixing, mixture again.At last will be for the first time, mixture merges mixing again.Use again the tablet press machine compressing tablet, make the soya-bean polypeptides healthy tablet.Every weight is 1g.
Embodiment 2
A kind of soya-bean polypeptides healthy tablet, it is to be made by the raw material of following proportioning, soy peptide powder 9 weight portions, xylitol 8 weight portions, WPC 1 weight portion, Dextran 35 weight portion, maltodextrin 30 weight portions, vegetable fat powder 2 weight portions, dolomol 0.4 weight portion, Sucralose 0.005 weight portion, coconut milk essence 0.4 weight portion, superfine silica gel powder 0.5 weight portion, ketone 0.3 weight portion, milk flavour 0.3 weight portion of muttering of pouting.The preparation method is with embodiment 1.
Embodiment 3
A kind of soya-bean polypeptides healthy tablet, it is to be made by the raw material of following proportioning, soy peptide powder 7.5 weight portions, xylitol 15 weight portions, WPC 0.8 weight portion, Gentran 40 weight portion, maltodextrin 28 weight portions, vegetable fat powder 3 weight portions, dolomol 0.32 weight portion, Sucralose 0.008 weight portion, coconut milk essence 0.3 weight portion, superfine silica gel powder 0.7 weight portion, ketone 0.23 weight portion, milk flavour 0.4 weight portion of muttering of pouting.The preparation method is with embodiment 1.
Claims (1)
1. a soya-bean polypeptides healthy tablet is characterized in that, it is to be made by the raw material of following weight proportioning,
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101089719A CN103355578A (en) | 2012-04-06 | 2012-04-06 | Soybean peptide nutritional and health tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101089719A CN103355578A (en) | 2012-04-06 | 2012-04-06 | Soybean peptide nutritional and health tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103355578A true CN103355578A (en) | 2013-10-23 |
Family
ID=49358528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101089719A Pending CN103355578A (en) | 2012-04-06 | 2012-04-06 | Soybean peptide nutritional and health tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103355578A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104799273A (en) * | 2014-01-27 | 2015-07-29 | 中粮营养健康研究院有限公司 | Soybean peptide particle preparation method, soybean peptide particle and soybean peptide particle drink |
| CN105854002A (en) * | 2016-01-15 | 2016-08-17 | 上海荣神生物化学有限公司 | Polypeptide powder composition and tablet and preparation method thereof |
| CN106617072A (en) * | 2016-12-20 | 2017-05-10 | 广州莱可福生物科技有限公司 | Phytosterol compound lipid-decreasing formula and preparation method for tablet thereof |
| CN107950851A (en) * | 2017-11-13 | 2018-04-24 | 江苏大学 | One kind is without bitter taste complex polypeptide powder |
| CN110338205A (en) * | 2019-07-29 | 2019-10-18 | 黄河水利职业技术学院 | A functional chiffon cake suitable for the elderly and its making method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1515185A (en) * | 2003-08-27 | 2004-07-28 | 任国谱 | Peptide base protein nutrient |
| CN1692836A (en) * | 2005-06-16 | 2005-11-09 | 欧阳康乐 | A multivariate solid drink that quickly replenishes energy and nutrition |
| CN101036519A (en) * | 2006-03-13 | 2007-09-19 | 中食肽灵（北京）生物科技有限公司 | Nutritive powder and its making process |
-
2012
- 2012-04-06 CN CN2012101089719A patent/CN103355578A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1515185A (en) * | 2003-08-27 | 2004-07-28 | 任国谱 | Peptide base protein nutrient |
| CN1692836A (en) * | 2005-06-16 | 2005-11-09 | 欧阳康乐 | A multivariate solid drink that quickly replenishes energy and nutrition |
| CN101036519A (en) * | 2006-03-13 | 2007-09-19 | 中食肽灵（北京）生物科技有限公司 | Nutritive powder and its making process |
Non-Patent Citations (2)
| Title |
|---|
| 樊秀花等: "大豆肽口含片的制备工艺研究", 《农产品加工 创新版》 * |
| 邵伟等: "大豆多肽咀嚼片的研制", 《中国酿造》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104799273A (en) * | 2014-01-27 | 2015-07-29 | 中粮营养健康研究院有限公司 | Soybean peptide particle preparation method, soybean peptide particle and soybean peptide particle drink |
| CN105854002A (en) * | 2016-01-15 | 2016-08-17 | 上海荣神生物化学有限公司 | Polypeptide powder composition and tablet and preparation method thereof |
| CN106617072A (en) * | 2016-12-20 | 2017-05-10 | 广州莱可福生物科技有限公司 | Phytosterol compound lipid-decreasing formula and preparation method for tablet thereof |
| CN107950851A (en) * | 2017-11-13 | 2018-04-24 | 江苏大学 | One kind is without bitter taste complex polypeptide powder |
| CN110338205A (en) * | 2019-07-29 | 2019-10-18 | 黄河水利职业技术学院 | A functional chiffon cake suitable for the elderly and its making method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6232412B2 (en) | Motor function improver | |
| US8835383B2 (en) | Method for controlling the digestive coagulation of proteins | |
| US8652544B2 (en) | Chia seed composition | |
| CN102125099B (en) | Yellow health-preserving milk and preparation method thereof | |
| CN103355578A (en) | Soybean peptide nutritional and health tablet | |
| CN103844249A (en) | Nutritional food, and preparation method thereof | |
| EP2648550B1 (en) | Early stimulation of taste and/or flavour acceptance | |
| JP5922863B2 (en) | Motor function improver | |
| US9974326B2 (en) | Scoopable instant protein bone- or meat-based protein supplement powder | |
| CN101095490A (en) | A kind of preparation method of flavor chickpea ball | |
| KR20190091768A (en) | Health assistance food for promoting growth | |
| CN103355577A (en) | Soybean peptide nutritional and health granule | |
| CN104720069B (en) | A kind of Chinese yam-Chinese date vitamin enrichment solid beverage and preparation method thereof | |
| CN103932134B (en) | A kind of instant noodles toppings bag | |
| CN106689383A (en) | Composite protein peptide high-calcium walnut powder and production technology thereof | |
| CN104757689A (en) | Solid beverage with pine pollen, taurine and vitamins, and preparation method of the solid beverage | |
| CN109198347A (en) | A kind of soybean peptide solid beverage and its application | |
| JP2012223161A (en) | Composition containing plant-derived component and milk fat globule membrane | |
| CN104161120A (en) | Milk tea with randia cochinchinensis fruits | |
| JP6225199B2 (en) | Motor function improver | |
| CN104719485A (en) | Brown sugar-red date milk tea powder and preparation technology of brown sugar-red date milk tea powder | |
| JP6884302B2 (en) | A composition for preventing fatigue, which comprises black garlic and miso having a Na content of 2.0 wt% or less. | |
| CN104041888A (en) | Rock candy and fragrant pear beverage | |
| CN102813005A (en) | Peanut walnut powder | |
| CN102429218A (en) | A nutritious food suitable for middle aged and elderly people for health promotion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131023 |